Bimzelx 320 MG/2 ML autoinject 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0YC1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,276
Award facts
- Contract value 100% obligated
- $41,276.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $41,276.45 to AmerisourceBergen Drug Corp for BIMZELX 320 MG/2 ML auto-injectors on December 10, 2025, with an ultimate completion date of December 11, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical supply vehicle running through December 2026. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. BIMZELX is a biologic medication used to treat psoriasis and other inflammatory conditions, and this delivery order represents a routine fulfillment of the company's role as a critical pharmaceutical distributor for federal military and veteran healthcare systems.
As a child delivery order under a larger prime contract vehicle, this award demonstrates AmerisourceBergen's established capability to supply specialized pharmaceutical products to support military healthcare programs. The company serves as a major vendor for the Defense Health Agency and other federal healthcare systems, fulfilling orders across a broad spectrum of therapeutic domains. The DLA Troop Support Medical's Pharmaceutical Prime Vendor Global Program is structured to enable efficient procurement of essential medical commodities, and AmerisourceBergen's substantial contract history with the agency reflects its competitive standing and ability to meet federal procurement requirements at scale.
Quick answers
Who was awarded contract SPE2DR26F0YC1?
SPE2DR26F0YC1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F0YC1 worth?
The government has obligated $41,276 on SPE2DR26F0YC1.
Is contract SPE2DR26F0YC1 an order under another contract?
Yes. SPE2DR26F0YC1 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0YC1 competed?
The extent of competition for SPE2DR26F0YC1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award